Prevention of severe lung immunopathology associated with influenza infection through adeno-associated virus vector administration
Abstract Background Influenza A viruses (IAVs) have long posed a threat to humans, occasionally causing significant morbidity and mortality. The initial immune response is triggered by infected epithelial cells, alveolar macrophages and dendritic cells. However, an exaggerated innate immune response...
Main Authors: | Eun Ah Choi, Hi Jung Park, Sung Min Choi, Jae Il Lee, Kyeong Cheon Jung |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-10-01
|
Series: | Laboratory Animal Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s42826-023-00177-0 |
Similar Items
-
Adeno‐associated virus‐vectored influenza vaccine elicits neutralizing and Fcγ receptor‐activating antibodies
by: Daniel E Demminger, et al.
Published: (2020-05-01) -
Adeno-associated virus vector-based gene therapies for pediatric diseases
by: Kazuhiro Muramatsu, et al.
Published: (2023-02-01) -
Immunopathology of emerging and re-emerging viral infections: an updated overview
by: Dimpu Gogoi, et al.
Published: (2024-04-01) -
Advanced biomanufacturing and evaluation of adeno-associated virus
by: Kai Chen, et al.
Published: (2024-02-01) -
Adeno-associated virus receptor complexes and implications for adeno-associated virus immune neutralization
by: Edward E. Large, et al.
Published: (2023-02-01)